Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders.

Down syndrome GABAergic transmission KCC2 NKCC1 NKCC2 autism brain disorders chloride homeostasis drug discovery small molecule

Journal

Chem
ISSN: 2451-9294
Titre abrégé: Chem
Pays: United States
ID NLM: 101688902

Informations de publication

Date de publication:
06 Aug 2020
Historique:
received: 13 02 2020
revised: 14 04 2020
accepted: 11 06 2020
entrez: 21 8 2020
pubmed: 21 8 2020
medline: 21 8 2020
Statut: epublish

Résumé

Aberrant expression ratio of Cl

Identifiants

pubmed: 32818158
doi: 10.1016/j.chempr.2020.06.017
pii: S2451-9294(20)30298-9
pmc: PMC7427514
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2073-2096

Subventions

Organisme : Telethon
ID : TCP15021
Pays : Italy

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

A.C. and L.C. are named as co-inventors on the following granted patent: US 9,822,368; EP 3083959; JP 6490077; A.C. and L.C. are named as co-inventors on the patent application WO 2018/189225. A.S., M.B., J.A.O., A.C., M.D.V., and L.C. are named as co-inventors on patent application IT 102019000004929.

Références

Neuropharmacology. 2020 Jan 1;162:107754
pubmed: 31476353
Br J Pharmacol. 1997 Mar;120(5):741-8
pubmed: 9138676
J Child Neurol. 2009 May;24(5):572-6
pubmed: 19406757
Epilepsy Behav. 2016 Jun;59:42-9
pubmed: 27088517
Nat Med. 2013 Nov;19(11):1524-8
pubmed: 24097188
Neuron. 1991 Mar;6(3):333-44
pubmed: 1672071
EBioMedicine. 2017 Jul;21:94-103
pubmed: 28679472
J Neurosci. 2012 Jul 4;32(27):9217-27
pubmed: 22764230
Exp Neurobiol. 2015 Dec;24(4):273-84
pubmed: 26713076
BMJ Case Rep. 2014 Jan 31;2014:
pubmed: 24488662
Neurosci Biobehav Rev. 2018 Jul;90:260-271
pubmed: 29729285
Ann Neurol. 2014 Apr;75(4):550-62
pubmed: 24615913
Nat Genet. 1995 Oct;11(2):177-84
pubmed: 7550346
Front Neurosci. 2019 Apr 24;13:310
pubmed: 31068771
Nat Protoc. 2006;1(5):2406-15
pubmed: 17406484
Clin Neuropharmacol. 2016 Jan-Feb;39(1):57-9
pubmed: 26757306
Front Cell Neurosci. 2016 Apr 14;10:90
pubmed: 27147965
Transl Psychiatry. 2012 Dec 11;2:e202
pubmed: 23233021
Mol Autism. 2018 Jun 14;9:36
pubmed: 29946415
Front Cell Neurosci. 2017 Mar 07;11:54
pubmed: 28326014
Nat Med. 2017 Dec 7;23(12):1396-1398
pubmed: 29216044
Epilepsia. 2012 Jun;53 Suppl 1:18-25
pubmed: 22612805
Neuropharmacology. 2018 Dec;143:186-204
pubmed: 30248303
Sci Rep. 2018 Feb 26;8(1):3602
pubmed: 29483603
Acta Paediatr. 2010 Dec;99(12):1885-8
pubmed: 20608900
Trends Neurosci. 2017 Sep;40(9):536-554
pubmed: 28818303
Auris Nasus Larynx. 2009 Apr;36(2):135-9
pubmed: 18606512
Nat Med. 2017 Dec 7;23(12):1394-1396
pubmed: 29216042
Schizophr Res. 2017 Jun;184:145-146
pubmed: 27956008
Epilepsia. 2013 Jan;54(1):e9-12
pubmed: 23061490
Nat Genet. 1999 Jun;22(2):192-5
pubmed: 10369265
Sci Rep. 2018 Aug 30;8(1):13077
pubmed: 30166610
Acta Paediatr. 2013 Jun;102(6):e288-90
pubmed: 23647528
Science. 2014 Feb 7;343(6171):675-9
pubmed: 24503856
Transl Psychiatry. 2017 Mar 14;7(3):e1056
pubmed: 28291262
Acta Neuropathol Commun. 2019 Dec 3;7(1):196
pubmed: 31796123
Sci Transl Med. 2019 Jul 31;11(503):
pubmed: 31366578
Mamm Genome. 2011 Dec;22(11-12):685-91
pubmed: 21953412
Clin Neuropharmacol. 2016 Mar-Apr;39(2):115-7
pubmed: 26966887
PLoS One. 2012;7(4):e35373
pubmed: 22506078
Front Cell Neurosci. 2014 May 22;8:119
pubmed: 24904277
J Child Adolesc Psychopharmacol. 2015 Sep;25(7):585-8
pubmed: 26258842
Front Pediatr. 2014 Jul 08;2:70
pubmed: 25072038
Mov Disord. 2017 Nov;32(11):1600-1609
pubmed: 28782830
eNeuro. 2018 Oct 5;5(3):
pubmed: 30302388
Lancet Neurol. 2015 May;14(5):469-77
pubmed: 25765333
Autism. 2015 Feb;19(2):149-57
pubmed: 24343334
Brain Res. 2003 Jan 24;961(1):22-31
pubmed: 12535773
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7287-E7296
pubmed: 27803317
J Neurosci. 2007 May 9;27(19):5224-35
pubmed: 17494709
Pediatrics. 2015 Aug;136(2):e539-43
pubmed: 26216321
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5383-8
pubmed: 19279215
Nat Med. 2015 Apr;21(4):318-26
pubmed: 25774849
Clin J Am Soc Nephrol. 2015 May 7;10(5):852-62
pubmed: 25078421
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):751-6
pubmed: 26733678
PLoS One. 2013 Jul 19;8(7):e68851
pubmed: 23894354

Auteurs

Annalisa Savardi (A)

Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.
Università degli Studi di Genova, Via Balbi, 5, 16126 Genoa, Italy.

Marco Borgogno (M)

Molecular Modeling and Drug Discovery Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.

Roberto Narducci (R)

Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.

Giuseppina La Sala (G)

Molecular Modeling and Drug Discovery Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.

Jose Antonio Ortega (JA)

Molecular Modeling and Drug Discovery Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.

Maria Summa (M)

In Vivo Pharmacology Facility, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.

Andrea Armirotti (A)

Analytical Chemistry Facility, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.

Rosalia Bertorelli (R)

In Vivo Pharmacology Facility, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.

Andrea Contestabile (A)

Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.

Marco De Vivo (M)

Molecular Modeling and Drug Discovery Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.

Laura Cancedda (L)

Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.
Dulbecco Telethon Institute, Via Orus 2, 35129 Padova, Italy.

Classifications MeSH